BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17964041)

  • 1. Association of plasma levels of F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) with human atherosclerosis.
    Cavusoglu E; Kornecki E; Sobocka MB; Babinska A; Ehrlich YH; Chopra V; Yanamadala S; Ruwende C; Salifu MO; Clark LT; Eng C; Pinsky DJ; Marmur JD
    J Am Coll Cardiol; 2007 Oct; 50(18):1768-76. PubMed ID: 17964041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The F11 receptor (F11R/JAM-A) in atherothrombosis: overexpression of F11R in atherosclerotic plaques.
    Babinska A; Azari BM; Salifu MO; Liu R; Jiang XC; Sobocka MB; Boo D; Al Khoury G; Deitch JS; Marmur JD; Ehrlich YH; Kornecki E
    Thromb Haemost; 2007 Feb; 97(2):272-81. PubMed ID: 17264957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of the F11R gene reveals a role for F11R/JAM-A in the migration of inflamed vascular smooth muscle cells and in atherosclerosis.
    Azari BM; Marmur JD; Salifu MO; Cavusoglu E; Ehrlich YH; Kornecki E; Babinska A
    Atherosclerosis; 2010 Sep; 212(1):197-205. PubMed ID: 20627246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated plasma level of soluble F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) in hypertension.
    Ong KL; Leung RY; Babinska A; Salifu MO; Ehrlich YH; Kornecki E; Wong LY; Tso AW; Cherny SS; Sham PC; Lam TH; Lam KS; Cheung BM
    Am J Hypertens; 2009 May; 22(5):500-5. PubMed ID: 19214165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional inhibition of F11 receptor (F11R/junctional adhesion molecule-A/JAM-A) activity by a F11R-derived peptide in breast cancer and its microenvironment.
    Bednarek R; Selmi A; Wojkowska D; Karolczak K; Popielarski M; Stasiak M; Salifu MO; Babinska A; Swiatkowska M
    Breast Cancer Res Treat; 2020 Jan; 179(2):325-335. PubMed ID: 31650345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the soluble F11 receptor and markers of inflammation in hemodialysis patients.
    Salifu MO; Kolff Q; Murty P; Haria DM; Zimpa M; Shakeel M; Lee H; Kornecki E; Babinska A
    J Investig Med; 2007 Apr; 55(3):115-9. PubMed ID: 17481380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. F11-receptor (F11R/JAM) mediates platelet adhesion to endothelial cells: role in inflammatory thrombosis.
    Babinska A; Kedees MH; Athar H; Ahmed T; Batuman O; Ehrlich YH; Hussain MM; Kornecki E
    Thromb Haemost; 2002 Nov; 88(5):843-50. PubMed ID: 12428104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cytokine tumor necrosis factor-alpha and interleukin-6 associated with the severity of coronary artery disease: indicators of an active inflammatory burden?
    Gotsman I; Stabholz A; Planer D; Pugatsch T; Lapidus L; Novikov Y; Masrawa S; Soskolne A; Lotan C
    Isr Med Assoc J; 2008 Jul; 10(7):494-8. PubMed ID: 18751625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A peptide antagonist of F11R/JAM-A reduces plaque formation and prolongs survival in an animal model of atherosclerosis.
    Babinska A; Clement CC; Przygodzki T; Talar M; Li Y; Braun M; Wzorek J; Swiatkowska M; Ehrlich YH; Kornecki E; Watala C; Salifu MO
    Atherosclerosis; 2019 May; 284():92-101. PubMed ID: 30877938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling pathways of the F11 receptor (F11R; a.k.a. JAM-1, JAM-A) in human platelets: F11R dimerization, phosphorylation and complex formation with the integrin GPIIIa.
    Sobocka MB; Sobocki T; Babinska A; Hartwig JH; Li M; Ehrlich YH; Kornecki E
    J Recept Signal Transduct Res; 2004 Feb; 24(1-2):85-105. PubMed ID: 15344881
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Babinska A; Clement CC; Li Y; Wzorek J; Przygodzki T; Talar M; Braun M; Swiatkowska M; Ehrlich YH; Kornecki E; Watala C; Salifu MO
    Data Brief; 2020 Jun; 30():105516. PubMed ID: 32395574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic structure, organization and promoter analysis of the human F11R/F11 receptor/junctional adhesion molecule-1/JAM-A.
    Sobocki T; Sobocka MB; Babinska A; Ehrlich YH; Banerjee P; Kornecki E
    Gene; 2006 Jan; 366(1):128-44. PubMed ID: 16337094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of a recombinant protein of the platelet F11 receptor (F11R) (JAM-1/JAM-A) in insect cells: F11R is naturally phosphorylated in the extracellular domain.
    Kedees MH; Babinska A; Swiatkowska M; Deitch J; Hussain MM; Ehrlich YH; Kornecki E
    Platelets; 2005 Mar; 16(2):99-109. PubMed ID: 15823866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription and translation of human F11R gene are required for an initial step of atherogenesis induced by inflammatory cytokines.
    Azari BM; Marmur JD; Salifu MO; Ehrlich YH; Kornecki E; Babinska A
    J Transl Med; 2011 Jun; 9():98. PubMed ID: 21703019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis.
    Aristoteli LP; Møller HJ; Bailey B; Moestrup SK; Kritharides L
    Atherosclerosis; 2006 Feb; 184(2):342-7. PubMed ID: 15979079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two regions of the human platelet F11-receptor (F11R) are critical for platelet aggregation, potentiation and adhesion.
    Babinska A; Kedees MH; Athar H; Sobocki T; Sobocka MB; Ahmed T; Ehrlich YH; Hussain MM; Kornecki E
    Thromb Haemost; 2002 Apr; 87(4):712-21. PubMed ID: 12008956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F11R/JAM-A: why do platelets express a molecule which is also present in tight junctions?
    Kamola P; Babinska A; Przygodzki T
    Platelets; 2023 Dec; 34(1):2214618. PubMed ID: 37246517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated in vivo thrombin formation independently predicts the presence and severity of CT angiographic coronary atherosclerosis.
    Borissoff JI; Joosen IA; Versteylen MO; Spronk HM; ten Cate H; Hofstra L
    JACC Cardiovasc Imaging; 2012 Dec; 5(12):1201-10. PubMed ID: 23236969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serum TRAIL level with coronary artery disease.
    Mori K; Ikari Y; Jono S; Shioi A; Ishimura E; Emoto M; Inaba M; Hara K; Nishizawa Y
    Thromb Res; 2010 Apr; 125(4):322-5. PubMed ID: 20034655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory markers in a 2-year follow-up of coronary artery disease.
    Mizia-Stec K; Gasior Z; Zahorska-Markiewicz B; Holecki M; Kumor P
    Heart Vessels; 2006 Sep; 21(5):302-8. PubMed ID: 17151818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.